Medullary thyroid carcinoma – Adverse events during systemic treatment: risk-benefit ratio (2017)
- Authors:
- Autor USP: MACIEL, LEA MARIA ZANINI - FMRP
- Unidade: FMRP
- DOI: 10.1590/2359-3997000000267
- Subjects: CARCINOMA NEUROENDÓCRINO; INIBIDORES DE ENZIMAS; PROTEÍNAS QUINASES; NEOPLASIAS DA TIREOIDE
- Keywords: MEDULLARY THYROID CARCINOMA; SYSTEMIC TREATMENT; TYROSINE KINASE INHIBITORS; ADVERSE EFFECTS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Archives of Endocrinology and Metabolism
- ISSN: 2359-3997
- Volume/Número/Paginação/Ano: v. 61, n. 4, p. 398-402, 2017
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
MACIEL, Léa Maria Zanini e MAGALHÃES, Patricia KüMnzle Ribeiro. Medullary thyroid carcinoma – Adverse events during systemic treatment: risk-benefit ratio. Archives of Endocrinology and Metabolism, v. 61, n. 4, p. 398-402, 2017Tradução . . Disponível em: https://doi.org/10.1590/2359-3997000000267. Acesso em: 19 abr. 2024. -
APA
Maciel, L. M. Z., & Magalhães, P. K. M. R. (2017). Medullary thyroid carcinoma – Adverse events during systemic treatment: risk-benefit ratio. Archives of Endocrinology and Metabolism, 61( 4), 398-402. doi:10.1590/2359-3997000000267 -
NLM
Maciel LMZ, Magalhães PKMR. Medullary thyroid carcinoma – Adverse events during systemic treatment: risk-benefit ratio [Internet]. Archives of Endocrinology and Metabolism. 2017 ; 61( 4): 398-402.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1590/2359-3997000000267 -
Vancouver
Maciel LMZ, Magalhães PKMR. Medullary thyroid carcinoma – Adverse events during systemic treatment: risk-benefit ratio [Internet]. Archives of Endocrinology and Metabolism. 2017 ; 61( 4): 398-402.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1590/2359-3997000000267 - Secrecao basal ultra e infradiana dos hormonios luteinizante, foliculo-estimulante e prolactina no homem adulto normal. Correlacao com testes de estimulo
- Frequent loss of heterozigosit of on the distal of chromosomes 3p and 17p in follicular thyroid carcinoma is rarely associated with mutations in the know tumor supressor genes
- Avaliação de disfunções tireóideas em pacientes com hepatite crônica C tratados com interferon alfa
- The effects of antithyroid drug treatment on thyroid hormone levels after 'ANT POT 131 I' ablation for graves' disease: a prospective randomized study
- Two novel mutations of thyroid hormone receptor beta induces thyroid hormone resistance syndrome in brazilian families
- Is frequency of etiologies and incidence of congenital hypothyroidism changing?
- Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the thyroid Department of the Brazilian Society of Endocrinology and Metabolism
- Consenso brasileiro para a abordagem clínica e tratamento do hipotireoidismo subclínico em adultos: recomendações do Departamento de Tireoide da Sociedade Brasileira de Endocrinologia e Metabologia
- Tratamento de nódulo autônomo e solitário da tireóide com injeção percutânea de etanol guiada pelo ultra-som
- Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma
Informações sobre o DOI: 10.1590/2359-3997000000267 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 002914914.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
